Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)
Article
Faehling, Martin, Schumann, Christian, Christopoulos, Petros, Hoffknecht, Petra, Alt, Jürgen, Horn, Marlitt, Eisenmann, Stephan
, Schlenska-Lange, Anke, Schütt, Philipp, Steger, Felix, Brückl, Wolfgang M. and Christoph, Daniel C.
(2020)
Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP).
Lung Cancer 150, pp. 114-122.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Lung Cancer | ||||
| Publisher | ELSEVIER IRELAND LTD | ||||
| Place of Publication | CLARE | ||||
| Volume | 150 | ||||
| Page Range | pp. 114-122 | ||||
| Date | 2020 | ||||
| Date of publication | 11 Oct 2021 12:35 | ||||
| Institutions | Medicine > Lehrstuhl für Strahlentherapie | ||||
| Identification Number |
| ||||
| Keywords | ; NSCLC; PD-L1; Checkpoint inhibitor; Survival; Real world | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 49466 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric